NICE Split Decision: Yes To Docetaxel, No To Paclitaxel For Early-Stage Breast Cancer
U.K. agency recommends use of Sanofi-Aventis’ Taxotere for early-stage breast cancer one month after prostate cancer nod.
U.K. agency recommends use of Sanofi-Aventis’ Taxotere for early-stage breast cancer one month after prostate cancer nod.